202 related articles for article (PubMed ID: 32987028)
1. Cell-autonomous hepatocyte-specific GP130 signaling is sufficient to trigger a robust innate immune response in mice.
Schumacher N; Yan K; Gandraß M; Müller M; Krisp C; Häsler R; Carambia A; Nofer JR; Bernardes JP; Khouja M; Thomsen I; Chalupsky K; Bolik J; Hölscher C; Wunderlich T; Herkel J; Rosenstiel P; Schramm C; Schlüter H; Renné T; Mittrücker HW; Rose-John S; Schmidt-Arras D
J Hepatol; 2021 Feb; 74(2):407-418. PubMed ID: 32987028
[TBL] [Abstract][Full Text] [Related]
2. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function.
Sander LE; Sackett SD; Dierssen U; Beraza N; Linke RP; Müller M; Blander JM; Tacke F; Trautwein C
J Exp Med; 2010 Jul; 207(7):1453-64. PubMed ID: 20530204
[TBL] [Abstract][Full Text] [Related]
3. Molecular dissection of gp130-dependent pathways in hepatocytes during liver regeneration.
Dierssen U; Beraza N; Lutz HH; Liedtke C; Ernst M; Wasmuth HE; Trautwein C
J Biol Chem; 2008 Apr; 283(15):9886-95. PubMed ID: 18216023
[TBL] [Abstract][Full Text] [Related]
4. Lack of glycoprotein 130/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitis.
Plum W; Tschaharganeh DF; Kroy DC; Corsten E; Erschfeld S; Dierssen U; Wasmuth H; Trautwein C; Streetz KL
Am J Pathol; 2010 May; 176(5):2236-46. PubMed ID: 20382701
[TBL] [Abstract][Full Text] [Related]
5. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
Klein C; Wüstefeld T; Assmus U; Roskams T; Rose-John S; Müller M; Manns MP; Ernst M; Trautwein C
J Clin Invest; 2005 Apr; 115(4):860-9. PubMed ID: 15761498
[TBL] [Abstract][Full Text] [Related]
6. Gp130-dependent release of acute phase proteins is linked to the activation of innate immune signaling pathways.
Luchtefeld M; Preuss C; Rühle F; Bogalle EP; Sietmann A; Figura S; Müller W; Grote K; Schieffer B; Stoll M
PLoS One; 2011 May; 6(5):e19427. PubMed ID: 21573245
[TBL] [Abstract][Full Text] [Related]
7. Lack of hepatic c-Met and gp130 expression is associated with an impaired antibacterial response and higher lethality after bile duct ligation.
Giebeler A; Brandenburg LO; Kaldenbach M; Erschfeld S; Wasmuth H; Wruck C; Trautwein C; Streetz KL
Lab Invest; 2012 Dec; 92(12):1726-37. PubMed ID: 22986785
[TBL] [Abstract][Full Text] [Related]
8. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo.
Pietrangelo A; Dierssen U; Valli L; Garuti C; Rump A; Corradini E; Ernst M; Klein C; Trautwein C
Gastroenterology; 2007 Jan; 132(1):294-300. PubMed ID: 17241879
[TBL] [Abstract][Full Text] [Related]
9. Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration.
Lam SP; Luk JM; Man K; Ng KT; Cheung CK; Rose-John S; Lo CM
Liver Transpl; 2010 Oct; 16(10):1195-206. PubMed ID: 20879018
[TBL] [Abstract][Full Text] [Related]
10. Glycoprotein 130-dependent pathways in host hepatocytes are important for liver repopulation in mice.
Tschaharganeh DF; Kaldenbach M; Erschfeld S; Tischendorf JJ; Trautwein C; Streetz KL
Liver Transpl; 2010 Jan; 16(1):23-32. PubMed ID: 20035522
[TBL] [Abstract][Full Text] [Related]
11. Lack of gp130 expression in hepatocytes promotes liver injury.
Streetz KL; Wüstefeld T; Klein C; Kallen KJ; Tronche F; Betz UA; Schütz G; Manns MP; Müller W; Trautwein C
Gastroenterology; 2003 Aug; 125(2):532-43. PubMed ID: 12891556
[TBL] [Abstract][Full Text] [Related]
12. IL-6 regulates neutrophil trafficking during acute inflammation via STAT3.
Fielding CA; McLoughlin RM; McLeod L; Colmont CS; Najdovska M; Grail D; Ernst M; Jones SA; Topley N; Jenkins BJ
J Immunol; 2008 Aug; 181(3):2189-95. PubMed ID: 18641358
[TBL] [Abstract][Full Text] [Related]
13. Lack of interleukin-6/glycoprotein 130/signal transducers and activators of transcription-3 signaling in hepatocytes predisposes to liver steatosis and injury in mice.
Kroy DC; Beraza N; Tschaharganeh DF; Sander LE; Erschfeld S; Giebeler A; Liedtke C; Wasmuth HE; Trautwein C; Streetz KL
Hepatology; 2010 Feb; 51(2):463-73. PubMed ID: 19918973
[TBL] [Abstract][Full Text] [Related]
14. Bile acids inhibit interleukin-6 signaling via gp130 receptor-dependent and -independent pathways in rat liver.
Graf D; Kohlmann C; Haselow K; Gehrmann T; Bode JG; Häussinger D
Hepatology; 2006 Nov; 44(5):1206-17. PubMed ID: 17058237
[TBL] [Abstract][Full Text] [Related]
15. Local and systemic effects of interleukin-6 (IL-6) in inflammation and cancer.
Rose-John S
FEBS Lett; 2022 Mar; 596(5):557-566. PubMed ID: 34738234
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation.
Gehrke N; Hövelmeyer N; Waisman A; Straub BK; Weinmann-Menke J; Wörns MA; Galle PR; Schattenberg JM
J Hepatol; 2018 May; 68(5):986-995. PubMed ID: 29366909
[TBL] [Abstract][Full Text] [Related]
17. IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3.
Greenhill CJ; Rose-John S; Lissilaa R; Ferlin W; Ernst M; Hertzog PJ; Mansell A; Jenkins BJ
J Immunol; 2011 Jan; 186(2):1199-208. PubMed ID: 21148800
[TBL] [Abstract][Full Text] [Related]
18. IL-6 controls the innate immune response against Listeria monocytogenes via classical IL-6 signaling.
Hoge J; Yan I; Jänner N; Schumacher V; Chalaris A; Steinmetz OM; Engel DR; Scheller J; Rose-John S; Mittrücker HW
J Immunol; 2013 Jan; 190(2):703-11. PubMed ID: 23241882
[TBL] [Abstract][Full Text] [Related]
19. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
[TBL] [Abstract][Full Text] [Related]
20. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.
Kim H; Baumann H
Mol Cell Biol; 1999 Aug; 19(8):5326-38. PubMed ID: 10409724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
